S. 5004: Cancer Drug Parity Act of 2026

S. 5004 is a federal bill in the 119th Congress. Cancer patients taking prescription pills at home often face much higher out of pocket costs than patients receiving intravenous treatments in a doctor office, because insurance plans traditionally classify pills under standard prescription drug tiers with… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.